دورية أكاديمية
أعرض في EDS

Successful Removal of Six Levonorgestrel Silastic Subcutaneous Implants (Norplant) 25 Years After Insertion: A Case Report.

التفاصيل البيبلوغرافية
العنوان: Successful Removal of Six Levonorgestrel Silastic Subcutaneous Implants (Norplant) 25 Years After Insertion: A Case Report.
المؤلفون: Old EA; Department of Internal Medicine, Mayo Clinic, Jacksonville, USA., Gajarawala S; Department of Medical and Surgical Gynecology, Mayo Clinic, Jacksonville, USA.; Department of Internal Medicine, Mayo Clinic, Jacksonville, USA., Knight DR; Department of Internal Medicine, Mayo Clinic, Jacksonville, USA., Pak K; Department of Internal Medicine, Mayo Clinic, Jacksonville, USA., Carrubba AR; Department of Medical and Surgical Gynecology, Mayo Clinic, Jacksonville, USA.
المصدر: Cureus [Cureus] 2024 Jul 01; Vol. 16 (7), pp. e63585. Date of Electronic Publication: 2024 Jul 01 (Print Publication: 2024).
نوع المنشور: Case Reports; Journal Article
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Levonorgestrel-releasing silastic implants are a form of subdermal contraception that utilizes implanted silastic rods to release levonorgestrel, providing long-acting reversible contraception over an extended period of time. This case report presents a female who had lost a significant amount of weight after receiving levonorgestrel-releasing implants 25 years prior. During the elapsed period, the rods were palpable and uncomfortable. She had previously been unable to find a provider willing to remove the implants. This case highlights the possible complications surrounding the removal of levonorgestrel silastic subcutaneous implants and the careful consideration required when the implant has been in place for an extended period.
Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
(Copyright © 2024, Old et al.)
References: Best Pract Res Clin Obstet Gynaecol. 2020 Jul;66:28-40. (PMID: 32014434)
Hand (N Y). 2013 Mar;8(1):92-6. (PMID: 24426901)
Contraception. 1998 Feb;57(2):99-101. (PMID: 9589836)
J Fam Plann Reprod Health Care. 2008 Jan;34(1):9-12. (PMID: 18201397)
Int J Fertil. 1991;36 Suppl 3:51-6. (PMID: 1687404)
Arch Dermatol. 1995 Sep;131(9):1064-8. (PMID: 7661610)
Obstet Gynecol. 1995 Apr;85(4):543-8. (PMID: 7898830)
J Fam Pract. 1995 Feb;40(2):184-6. (PMID: 7852942)
Contracept Rep. 1994 Nov;5(5):4-12. (PMID: 12288249)
Int J Gynaecol Obstet. 1985 Jun;23(3):223-7. (PMID: 2865186)
Ann Med. 1993 Apr;25(2):155-60. (PMID: 8489753)
Drug Saf. 2003;26(5):303-35. (PMID: 12650633)
Contraception. 1996 Mar;53(3):159-61. (PMID: 8689880)
فهرسة مساهمة: Keywords: contraception ; contraceptive agents; iatrogenic disease; levonorgestrel; norplant
تواريخ الأحداث: Date Created: 20240801 Latest Revision: 20240802
رمز التحديث: 20240802
مُعرف محوري في PubMed: PMC11290371
DOI: 10.7759/cureus.63585
PMID: 39087147
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.63585